These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 26514514)
1. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma. Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514 [TBL] [Abstract][Full Text] [Related]
2. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma. Nabih MI; Aref WM; Fathy MM Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis. Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976 [TBL] [Abstract][Full Text] [Related]
4. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma. Zhou C; Zhou HJ; Zhang XF; Lou LL; Ye QH; Zheng Y; Wang J; Zhu HT; Dong QZ; Jia HL; Zhu WW; Guo L; Zhao Y; Gao DM; Qin LX Ann Surg Oncol; 2013 Mar; 20(3):929-37. PubMed ID: 23203407 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma. Abu El Makarem MA; Abdel-Aleem A; Ali A; Saber R; Shatat M; Rahem DA; Sayed D Ann Hepatol; 2011; 10(3):296-305. PubMed ID: 21677331 [TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Yao M; Zhao J; Lu F Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109 [TBL] [Abstract][Full Text] [Related]
8. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening. Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937 [TBL] [Abstract][Full Text] [Related]
9. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection. Song X; Wu A; Ding Z; Liang S; Zhang C Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467 [TBL] [Abstract][Full Text] [Related]
10. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. Duarte-Salles T; Misra S; Stepien M; Plymoth A; Muller D; Overvad K; Olsen A; Tjønneland A; Baglietto L; Severi G; Boutron-Ruault MC; Turzanski-Fortner R; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Bamia C; Pala V; Palli D; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez-Cantalejo E; Ardanaz E; Gavrila D; Dorronsoro M; Werner M; Hemmingsson O; Ohlsson B; Sjöberg K; Wareham NJ; Khaw KT; Bradbury KE; Gunter MJ; Cross AJ; Riboli E; Jenab M; Hainaut P; Beretta L Cancer Prev Res (Phila); 2016 Sep; 9(9):758-65. PubMed ID: 27339170 [TBL] [Abstract][Full Text] [Related]
11. Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy. Byeon H; Lee SD; Hong EK; Lee DE; Kim BH; Seo Y; Joo J; Han SS; Kim SH; Park SJ Pathol Res Pract; 2018 Jun; 214(6):814-820. PubMed ID: 29753515 [TBL] [Abstract][Full Text] [Related]
12. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517 [TBL] [Abstract][Full Text] [Related]
13. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer. Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517 [TBL] [Abstract][Full Text] [Related]
14. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal. Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma. Yang XP; Zhou LX; Yang QJ; Liu L; Cai Y; Ma SL Cancer Biomark; 2016 Sep; 17(3):271-279. PubMed ID: 27802203 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma. Jang ES; Jeong SH; Kim JW; Choi YS; Leissner P; Brechot C PLoS One; 2016; 11(3):e0151069. PubMed ID: 26986465 [TBL] [Abstract][Full Text] [Related]
17. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. da Costa AN; Plymoth A; Santos-Silva D; Ortiz-Cuaran S; Camey S; Guilloreau P; Sangrajrang S; Khuhaprema T; Mendy M; Lesi OA; Chang HK; Oh JK; Lee DH; Shin HR; Kirk GD; Merle P; Beretta L; Hainaut P Int J Cancer; 2015 Jan; 136(1):172-81. PubMed ID: 24803312 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B. Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396 [TBL] [Abstract][Full Text] [Related]
19. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma. Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813 [TBL] [Abstract][Full Text] [Related]
20. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis. Zhu M; Zheng J; Wu F; Kang B; Liang J; Heskia F; Zhang X; Shan Y J Med Virol; 2020 Dec; 92(12):3596-3603. PubMed ID: 32043608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]